Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
4.48M
-
Shares change
-
-287K
-
Total reported value, excl. options
-
$26.6M
-
Value change
-
-$1.73M
-
Number of buys
-
9
-
Number of sells
-
-13
-
Price
-
$5.93
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2019
29 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q3 2019.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.48M shares
of 15M outstanding shares and own 29.95% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (958K shares), Stonepine Capital Management, LLC (860K shares), DIMENSIONAL FUND ADVISORS LP (860K shares), RENAISSANCE TECHNOLOGIES LLC (469K shares), VANGUARD GROUP INC (392K shares), BlackRock Inc. (332K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (183K shares), ACADIAN ASSET MANAGEMENT LLC (101K shares), DALTON GREINER HARTMAN MAHER & CO (89.1K shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (53.8K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.